| Literature DB >> 29064657 |
Sompol Permpongkosol1, Supanun Aramay2, Thawanrat Vattanakul2, Sith Phongkitkarun2.
Abstract
INTRODUCTION ANDEntities:
Keywords: Magnetic Resonance Imaging, Laparoscopy ; Prostatectomy; Prostatic Neoplasms
Mesh:
Year: 2018 PMID: 29064657 PMCID: PMC6050549 DOI: 10.1590/S1677-5538.IBJU.2017.0260
Source DB: PubMed Journal: Int Braz J Urol ISSN: 1677-5538 Impact factor: 1.541
Figure 1Anthropometric measurements by magnetic resonance imaging. (A) angle between the pubic bone and the prostate gland in midline cut: hypointense T2 (pubic symphysis); B) depth of prostatic apex; C) curve of public bone.
Figure 2Anthropometric measurements by magnetic resonance imaging. (A) Work space transverse width (mm) on T1W image [AP: anterior peritoneum to anterior border of coccyx (inner border)] and Transverse: medial border of acetabulum; (B) Protrusion to bladder base (mm): most superior point of prostate in bladder to outer border of bladder wall.
Patient characteristics and perioperative outcomes.
| No. | Variable | Mean±SD | Median (IQR: Q3-Q1) |
|---|---|---|---|
| 1 | Age (years) | 69.61±8.30 | 71 (12.75: 75.75-63.00) |
| 2 | BMI (kg/m2) | 24.86±3.29 | 24.79 (4.23: 26.71-22.48) |
| 3 | Serum PSA (ng/ml) | 16.31±21.20 | 8.77 (11.77: 17.20-5.42) |
| 4 | Prostate volume (cc) | 32.82±17.80 | 29.75 (13.95: 36.60-22.65) |
| 5 | Operative time (hours) | 5.55±1.75 | 5.23 (2.69: 6.86-4.18) |
| 6 | Hospital stay (days) | 8.24±4.06 | 4 (4: 9-5) |
| 7 | Estimated blood loss (ml) | 725.30±539.50 | 600 (600: 900-300) |
SD: standard deviation; BMI: body mass index; PSA: prostate-specific antigen
Patient pathological reports and positive surgical margins.
| No. | Variable | N | Percentage (%) |
|---|---|---|---|
| 1 | Pathologic Gleason score | ||
| ≤6 | 29 | 30.85 | |
| 7 | 48 | 51.06 | |
| ≥8 | 14 | 14.89 | |
| 2 | Pathologic stage | ||
| T1 | 7 | 7.45 | |
| T2 | 42 | 44.68 | |
| T3 | 31 | 32.98 | |
| T4 | 2 | 2.13 | |
| 3 | Positive surgical margins | 17 | 18.09 |
Association among patient characteristics and prostate MRI and Using Univariate analysis using simple linear regression analysis.
| Variable of MRI | Mean±SD | BMI | PSA | Operative Time (hr) | Blood loss (ml) | Hospital stay (days) | Positive Margin | Pathological Gleason score | Pathological stage | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| c.c. | P | c.c. | P | c.c. | P | c.c. | P | c.c. | P | c.c. | P | c.c. | P | c.c. | P | ||
| Prostate volume | 32.717±17.41 | 0.02 | 0.409 | 0.01 | 0.942 | 0.00 | 0.996 | -0.00 | 0.932 | -0.02 | 0.551 | -0.00 | 0.801 | 0.01 | 0.471 | 0.00 | 0.415 |
| Angle between pubic bone and prostate (degree) | 53.24±8.68 | 0.01 | 0.897 | 0.19 | 0.471 | 0.03 | 0.163 | 0.01 | 0.296 | 0.03 | 0.592 | -0.01 | 0.165 | -0.02 | 0.454 | -0.00 | 0.702 |
| Depth of prosatic apex (mm) | 29.00±6.10 | -0.01 | 0.821 | 0.30 | 0.425 | 0.00 | 0.982 | 0.02 | 0.124 | -0.09 | 0.237 | 0.00 | 0.96 | 0.02 | 0.487 | 0.01 | 0.276 |
| Curve distance (mm) | 14.28±2.70 | -0.14 | 0.272 | -1.64 | 0.043 | -0.03 | 0.663 | -0.01 | 0.770 | -0.30 | 0.061 | 0.01 | 0.707 | 0.01 | 0.921 | 0.04 | 0.171 |
| Pubic angle 1 (degree) | 23.10±3.81 | -0.11 | 0.251 | -0.90 | 0.123 | -0.04 | 0.434 | 0.00 | 0.999 | -0.29 | 0.015 | 0.00 | 0.847 | 0.05 | 0.253 | 0.02 | 0.329 |
| Pubic angle 2 (degree) | 48.70±10.11 | 0.01 | 0.804 | -0.58 | 0.008 | -0.04 | 0.025 | 0.01 | 0.203 | -0.03 | 0.542 | -0.00 | 0.875 | -0.01 | 0.596 | -0.01 | 0.480 |
| Abd wall thickness (mm) | 20.00±6.36 | 0.09 | 0.117 | 0.40 | 0.252 | 0.01 | 0.670 | -0.00 | 0.901 | 0.12 | 0.087 | 0.01 | 0.408 | 0.00 | 0.971 | 0.01 | 0.264 |
| Work space AP (mm) | 139.51±10.83 | 0.03 | 0.403 | -0.37 | 0.076 | 0.00 | 0.927 | 0.01 | 0.399 | 0.04 | 0.372 | 0.01 | 0.055 | -0.01 | 0.770 | -0.00 | 0.866 |
| Work space transverse (mm) | 103.89±6.07 | 0.02 | 0.780 | -0.09 | 0.800 | 0.03 | 0.451 | 0.01 | 0.665 | -0.07 | 0.361 | -0.01 | 0.068 | -0.01 | 0.769 | 0.00 | 0.980 |
| Bladder protrusion (mm) | 2.80±4.56 | -0.01 | 0.856 | 0.97 | 0.049 | 0.02 | 0.606 | 0.02 | 0.177 | -0.05 | 0.612 | 0.00 | 0.894 | -0.06 | 0.114 | 0.02 | 0.360 |
| Retropubic fat | 3.20±2.02 | -0.03 | 0.854 | -2.12 | 0.057 | 0.00 | 0.979 | -0.02 | 0.663 | 0.30 | 0.187 | -0.01 | 0.540 | -0.10 | 0.245 | -0.05 | 0.177 |
| Periprostatic plexus diameter (mm) | 3.30 ±0.79 | 0.15 | 0.724 | -0.18 | 0.951 | 0.37 | 0.119 | 0.07 | 0.516 | -0.04 | 0.943 | 0.04 | 0.385 | -0.16 | 0.475 | 0.02 | 0.840 |
Abbreviation: BMI, body mass index; EBL, estimated blood loss; SD, standard deviation; c.c.; correlation coefficient
Association among PSA, Gleason grade and pathological stage and perioperative outcomes and using simple linear regression analysis.
| Variable of MRI | Operative Time (hr) | Blood loss (ml) | Hospital stay (days) | |||
|---|---|---|---|---|---|---|
| c.c. | P | c.c. | P | c.c. | P | |
| BMI | 0.06 | 0.281 | 0.04 | 0.159 | -0.05 | 0.734 |
| PSA | 0.02 | 0.035 | 0.01 | 0.100 | 0.01 | 0.535 |
| Positive margin | 0.42 | 0.390 | 0.13 | 0.563 | 1.82 | 0.116 |
| Pathological Gleason score | -0.19 | 0.092 | -0.06 | 0.258 | -0.18 | 0.489 |
| Pathological stage | -0.31 | 0.304 | -0.09 | 0.545 | -0.98 | 0.150 |
BMI, body mass index; PSA, Prostate specific antigen; c.c.; correlation coefficient